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Abstract
Introduction—Ambulatory care sensitive conditions (ACSCs) can be seen as failure of access or 
management in primary care settings. Identifying factors associated with ACSCs for individuals 
with an Intellectual Disability (ID) provide insight into potential interventions.
Method—To assess the association between emergency department (ED) ACSC visits and a 
number of demographic and health characteristics of South Carolina Medicaid members with ID. 
A retrospective cohort of adults with ID was followed from 2001 to 2011. Using ICD-9-CM 
codes, four ID subgroups, totalling 14 650 members, were studied.
Results—There were 106 919 ED visits, with 21 214 visits (19.8%) classified as ACSC. Of 
those, 82.9% were treated and released from EDs with costs averaging $578 per visit. People with 
mild and unspecified ID averaged greater than one ED visit per member year. Those with Down 
syndrome and other genetic cause ID had the lowest rates of ED visits but the highest percentage 
of ACSC ED visits that resulted in inpatient hospitalisation (26.6% vs. an average of 16.8% for 
other subgroups). When compared with other residential types, those residing at home with no 
health support services had the highest ED visit rate and were most likely to be discharged back to 
the community following an ED visit (85.2%). Adults residing in a nursing home had lower rates 
of ED visits but were most likely to be admitted to the hospital (38.9%) following an ED visit. 
Epilepsy and convulsions were the leading cause (29.6%) of ACSC ED visits across all subgroups 
and residential settings.
Conclusion—Prevention of ACSC ED visits may be possible by targeting adults with ID who 
live at home without health support services.
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Introduction
In the USA, approximately 1.2 million adults (0.5% of people aged 18 years or older) are 
estimated to have an ID (Brault 2010; Maulik et al. 2011). Many children and most adults 
with ID receive their healthcare coverage through Medicaid (Ervin & Merrick 2014). 
Compared with the general population, people with ID have poorer health, higher mortality 
rates and lower quality of healthcare (Perry et al. 2014; Slowie & Martin 2014). The health 
differences experienced by people with ID are, in part, attributed to inadequate primary care 
(Lennox & Kerr 1997; Balogh et al. 2013; Lennox et al. 2015). Moreover, people with ID 
have difficulty accessing care and finding providers who are knowledgeable about health 
issues that might be exacerbated by their underlying condition (Robertson et al. 2014; 
Lennox et al. 2015).
Ambulatory care sensitive conditions (ACSCs) are health problems that should be managed 
through a combination of outpatient treatment and self-care and, therefore, in many 
instances, should not require an emergency department (ED) visit or inpatient hospitalisation 
(Oster & Bindman 2003). Policy makers and researchers have used ACSC hospitalisations 
and ED visits as indicators of access to – and quality of – primary care (Oster & Bindman 
2003; Ansari et al. 2006; Agency for Healthcare Research and Quality 2007; Johnson et al. 
2012; Brownell et al. 2014; Bergamo et al. 2016).
Previous research has focused on rates of hospitalisation or ED visits for ACSC among the 
general population, the aged, persons receiving their healthcare coverage from Medicaid and 
members of racial and ethnic minority groups (Silver et al. 1997; Shi et al. 1999; Kozak et 
al. 2001; Laditka et al. 2003; Oster & Bindman 2003; Caminal et al. 2004; Laditka et al. 
2005; Ansari et al. 2006; Agency for Healthcare Research and Quality 2007; Johnson et al. 
2012; Brownell et al. 2014; Bergamo et al. 2016; Conway et al. 2016). Only recently has the 
ACSC treatment experience of people with ID been studied. A population-based study in the 
Canadian province of Manitoba reported that persons with ID had a higher rate of ACSC 
hospitalisations than people without ID, suggesting opportunities to improve access to – or 
the quality of – primary care (Balogh et al. 2010). Factors associated with ACSC 
hospitalisations among individuals with ID included demographic and socioeconomic 
characteristics, the presence of comorbid conditions and having visited a primary care 
physician in the last year (Balogh et al. 2011).
While the work of Balogh and colleagues (Balogh et al. 2010; Balogh et al. 2011) was 
instrumental in assessing the association between people with ID and factors associated with 
ACSC hospitalisation, some key variables that are relevant to the ID population, such as 
residential service setting, were not assessed. People with ID may qualify for residential 
services administered by state disability agencies, and it has been suggested that residential 
service setting might be an important factor to consider in assessing the health of people 
with ID (Braddock et al. 2008; Larson et al. 2014). In 2012, an estimated 635 000 (56%) 
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Americans with ID lived with family members; 207 000 (18%) resided in group homes; 123 
000 (11%) lived in supervised community settings; 85 000 (8%) resided in intermediate care 
facilities (ICFs); 59 000 (5%) lived in host/foster homes; and 28 000 (2%) resided in nursing 
homes (Rizzolo et al. 2013; Larson et al. 2014).
This study builds on the work by Balogh and colleagues by exploring factors associated with 
ACSC ED visits among Medicaid members resulting in either inpatient admission or ED 
discharge. In addition to residential setting, we included ID subgroup (e.g. mild ID), as well 
as demographics and health characteristics of South Carolina (SC) Medicaid members with 
ID. While previous studies have analysed the association between ACSC ED visits and 
Medicaid health insurance coverage, the findings were not assessed for Medicaid members 
with ID (Oster & Bindman 2003; Gingold et al. 2016). A substantial proportion of adults 
with ID, who are insured by Medicaid, live at home and receive community-based health 
services and some disability support services from a state authorised disability service 
provider. Knowing whether ACSC ED visits vary by ID subgroup and residential setting 
might help in the design of testable interventions to improve access to – or quality of – 
primary care. The hypotheses for this study were ACSC ED visits among adults with ID: (1) 
would vary by residential setting and (2) would vary by ID category. We did not have a 
priori hypotheses about the specific patterns of ED visits across categories of ID and 
residential type, but we did anticipate that ED visit rates would generally be higher for those 
with less severe disability and for those in less restrictive/less supportive residential settings.
Methods
Data sources
Data housed at the South Carolina Revenue and Fiscal Affairs Office, Health and 
Demographic Section (H&D) and utilised for this project originated from Medicaid, an all-
payer hospital discharge dataset (HDD), the Department of Disabilities and Special Needs 
and the Department of Social Services. Data use agreements were obtained from 
participating organisations. The analyses were performed at the H&D, and non-H&D 
investigators received aggregated estimates for review. Procedures for the protection of 
human subjects were reviewed and approved by the University of South Carolina 
institutional review board.
Medicaid is public health insurance that is jointly funded by federal and state governments 
and provides healthcare coverage to low-income individuals and those with disabilities 
including many children and most adults with ID (Ervin & Merrick 2014). Data from South 
Carolina Medicaid claims were searched for ICD-9-CM codes to identify members with ID 
for the period 2001–2011. Once the ID cohort was identified, additional databases housed at 
H&D were used to identify covariates and service utilisation. Variables of interest included 
age, race, sex, rurality of county, residential service setting, years of enrollment, 
supplemental nutrition assistance, primary care visits, ED visits and subsequent inpatient 
hospital admission, as well as timing of services.
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Case definitions for intellectual disability
We searched the South Carolina Medicaid fee-for-service and HMO claims for ICD-9-CM 
codes related to ID over the study period. Medicaid members who had one inpatient 
encounter or two other service encounters (excluding pharmacy claims) with an ID diagnosis 
code were identified as having an ID. The ICD-9-CM codes used were based on the 
disability-related condition algorithms available from the chronic conditions data warehouse 
of the Centers for Medicaid and Medicare Services (Centers for Medicaid and Medicare 
Services 2013). Members with ID and carrying a diagnosis of cerebral palsy, spina bifida or 
paralysis due to spinal cord injury or stroke were excluded because these comorbid 
conditions could have implications for care and could be potential confounders or effect 
modifiers, impacting both the residential status and the occurrence of ACSCs.
For this analysis, we focused on four subgroups of ID: (1) known genetic cause including 
Down syndrome; (2) mild; (3) moderate, severe and profound; and (4) unspecified. ID 
subgroups and corresponding ICD-9-CM codes are shown in Table 1. Adults with ID often 
receive multiple diagnosis codes from providers; therefore, we developed a hierarchy to 
assign each individual to a single subgroup. We always selected a more specific code over a 
general code. Therefore, we started with individuals who had a known genetic cause of ID 
regardless of the presence of any other codes. We then considered the following subgroups 
and possible combinations: mild, moderate to profound and unspecified. If a cohort member 
had a code for mild and unspecified IDs, we assigned him/her to the mild ID group; and if a 
member had a code for moderate to profound and unspecified ID, we assigned him or her to 
the moderate to profound ID group. If coded with both mild and moderate to profound IDs, 
we accepted the code noted on a medical specialty claim (neurology, genetics or psychiatry) 
over a code from a primary care claim. When there was no difference by provider type, we 
accepted the code used most often. This method of assigning categories of ID has been 
described elsewhere (McDermott et al. 2017).
Outcome measures were compiled for each year during the study period when cohort 
members were 22–64 years of age and enrolled at least 11 out of 12 months. All calendar 
years where member did not meet age and eligibility requirements were excluded.
Ambulatory care case-sensitive condition counts and costs
Once the ID cohort was established, we used an Agency for Health Care Research and 
Quality (AHRQ) Prevention Quality Indicators data tool to identify ED visits for ACSCs 
based on ICD-9 diagnosis codes (Agency for Healthcare Research and Quality 2015a). The 
AHRQ ACSC data tool was applied against an all-payer HDD that included ED visits from 
all acute-care, civilian hospitals within South Carolina. The data tool required the following 
elements: diagnosis and procedure fields, admission source and disposition status. ED visits 
could result in either an inpatient hospitalisation or a member could be treated and 
discharged from the ED. Visit charges were converted to costs by using the AHRQ 
Healthcare Cost and Utilisation Project inpatient cost-to-charge ratios (Agency for 
Healthcare Research and Quality 2013; Agency for Healthcare Research and Quality 2015b) 
and adjusted for inflation by using the 2010 Personal Health Care and Component Price 
Indices (D’Hoore et al. 1996).
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Covariates
Information on residential setting was compiled from Medicaid claims and the Department 
of Special Needs and divided into the following groups: (1) community settings, including 
supervised apartment living, assisted living facilities, boarding homes, group homes and 
community residential care facilities, and (2) nursing home facilities, ICFs for individuals 
with ID and rehabilitation facilities. ICF for individuals with ID is a Medicaid benefit that 
provides active treatment inclusive of residential and day services. This is an expensive and 
highly intensive service available to people with ID, with around-the-clock nurse 
supervision. If neither of the above residential service setting was identified, residential 
setting was designated as residing at ‘home’. Home was further divided into two categories 
based on current procedural terminology codes in the Medicaid claims file: (1) members 
receiving nursing services, adult day services with a health component or personal care 
services that included medication monitoring (home with health support) and (2) members 
not receiving such services (home without health support).
Comorbid conditions were identified by using the Charlson comorbidity index, a set of 
conditions associated with elevated mortality risk and defined by ICD-9-CM codes from 
claims data (Washington State Rural Health Research Center 2005). We created a 
dichotomous variable for having at least one comorbidity condition.
Primary care visits were estimated from the Medicaid claims data. A visit was considered 
primary care if (1) an office, other outpatient clinic or nursing home evaluation and 
management current procedural terminology code was noted on the encounter claim and (2) 
the rendering physician specialty was recorded as family practice, general practice, general 
internal medicine or paediatrician or the service was provided by nurse practitioner. The 
specific physician specialties were chosen because they are classified as primary care 
specialties by the American Association of Medical Colleges (Association of American 
Medical Colleges 2014). The specialists that were excluded are classified as internal 
medicine subspecialists, such as cardiology, pulmonology, gastroenterology and others. 
Thus, the internal medicine group classified as primary care providers are general internists, 
who do typically function as primary care providers in the USA. In addition, all-inclusive 
visits occurring in federally qualified health departments or rural health centres were 
counted as primary care visits.
To investigate the potentially preventive effects of primary care, we used an indicator 
variable to denote if at least one primary care visit occurred in the year prior to the first 
ACSC visit of each year. We also included other potential confounders of sex, race, age, 
receipt of Supplemental Nutrition Assistance Program (SNAP) and county type. Sex (male 
and female), race (white and other), SNAP participation (yes and no) and county type (urban 
and rural) were dichotomous variables, whereas age was a continuous variable. Eligibility 
for SNAP requires proof of household or individual income below the federal poverty level. 
The county type was determined by using the rural urban community area codes 
(Washington State Rural Health Research Center 2005). Covariate values for the time-
varying variables such as residence, age, comorbid conditions and primary care receipt were 
defined for each calendar year a cohort member was included in the analysis.
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Descriptive analyses
In addition to presenting demographic profiles by ID subgroup, we estimated expenditures 
associated with ACSC visits for the period of 2001–2011 from the all-payer HDD. We 
calculated the number and percentage of ED visits for those with ID that were due to ACSCs 
and their associated average and total costs. We stratified by ID subgroup, ACSC disposition 
(treated in the ED and admitted to the hospital as an inpatient or treated and discharged from 
the ED) and residential service setting and adjusted for each cohort member’s total number 
of years enrolled.
Statistical approach
Inference on generalised estimating equation (GEE) models assessed whether differences 
were significant in the number of ACSC services utilised among patients by ID condition 
group and residential service setting. The referent group consisted of those with mild ID and 
those living at home with no health management services. Each GEE model was estimated 
by using the GENMOD procedure in SAS 9.4 (SAS Version 9.4 n.d.) and specified a 
negative binomial distribution variance with the log link function. This approach is a 
generalisation of the Poisson regression model that is suitable for overdispersed (relative to 
the Poisson) count data. Incidence rate ratios were estimated as exponentiated regression 
coefficient estimates. To account for within-group correlation of repeated observations from 
the same person, GEE models with repeated statement were estimated to explicitly account 
for nonindependence. A false discovery rate procedure adjusted for simultaneous tests on 
multiple factors and adjusted p-values are shown (Holm 1979).
This study was funded by the Centers for Disease Control, National Center on Birth Defects 
and Developmental Disabilities, in partnership with the Association of University Centers on 
Disability.
Results
For the study period 2001–2011, we identified 14 650 individuals with ID enrolled for at 
least one calendar year and were between 22 and 64 years of age. The largest subgroup of ID 
consisted of members with moderate-to-profound ID (37.8%), followed by mild ID (33.8%), 
unspecified ID (16.4%) and Down syndrome/other genetic causes (11.9%). The descriptive 
characteristics of South Carolina Medicaid members with ID are shown in Table 2. Unless 
noted, characteristics are based on a member’s first enrolment year during the study period. 
The majority of members with ID were 22–34 years of age, and this was consistent across 
ID condition groups. Fifty-one per cent of those with ID were male. Overall, 51.1% of 
individuals with ID were African American and 43.8% were Caucasian. The racial makeup 
was similar across ID condition groups with the exception of those with Down syndrome/
other genetic causes where 32.6% identified as African American and 62.8% as Caucasian.
The average length of time enrolled in Medicaid when a member was 22–64 years of age 
during the 11-year study period was 7.3 years for ID overall; it was lowest for those with 
mild ID (6.6 years) and highest for those with moderate-to-profound ID (7.9 years). SNAP 
benefits were provided to 49.8% of those with ID and a majority (69.0%) lived in urban 
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areas. At least one comorbid condition was present in 38.0% of those with ID and ranged 
from 32.3% for those with mild ID to 47.4% for those with unspecified ID. The most 
common comorbidity indicated for those with mild and unspecified IDs was a mental health 
condition. A majority of those with ID (80.7%) had at least one primary care visit during the 
study period. By ID subgroup, having had at least one primary care visit during study period 
ranged from 79.0% for those with moderate-to-profound ID to 86.7% among those with 
Down syndrome/other genetic causes. Overall, 49.5% of those with ID lived at home with 
health services, 8.3% lived in the community in a group home or other supervised living 
arrangement, and 7.3% lived in a nursing home, ICF or other institutional setting. We 
presumed home without health services for the remaining 35.0%.
A total of 107 032 years were studied (an average of 7.3 years per person). Over the 11-year 
period, there were 106 919 ED visits, and 21 214 (19.8%) of those were determined to be for 
ACSCs; see Table 3. For most ED ACSC visits (82.9%), members were treated in the ED 
and discharged. The average length of stay for the 3630 ACSC visits with subsequent 
inpatient admission was 4.9 days. The average costs of an ED ACSC visit with an inpatient 
hospital admission were $7474 and $578 if treated and discharged. Those with mild and 
unspecified IDs had the highest unadjusted overall ED and ED due to ACSC rate per 
member (on average over one ED visit per member per year and one ACSC ED visit every 4 
years), while those with Down syndrome and other genetic cause group had the lowest 
ACSC rate per member. However, this subgroup had the highest percentage of visits 
requiring an inpatient stay. The home with no service monitoring of a member’s health had 
the highest overall ED and ACSC ED use rates. Nursing and group home members had the 
highest percentage of visits requiring an inpatient stay. Costs were highest for the Down 
syndrome and other genetic cause members and for those living in a nursing home or ICF.
The leading causes of ACSC visits are shown in Table 4. All ID subgroups and residential 
settings had a similar constellation of conditions accounting for the majority of ACSC ED 
visits. Notably, epilepsy was the leading cause of ACSC ED visits overall and across all ID 
subgroups and residential settings.
Adjusted incidence rate ratios for ACSC ED treated and discharged and ED visits requiring 
an inpatient hospitalisation are shown in Table 5. The ACSC ED treated and released 
discharge rates for the Down syndrome and moderate-to-profound ID condition groups were 
lower than those with mild ID subgroup rates (by 26.1% and 14.9%, respectively). No 
statistically significant difference was noted for the unspecified and mild ID subgroup 
comparison. Compared with home without nursing or adult day services with a health 
component, all three residential service settings had lower ACSC ED treated and released 
rates (range 16.1% to 31.5%). Those with Down syndrome had a 30.6% higher rate of 
ACSC ED treated and admitted to hospital in comparison with those with mild ID. There 
was no difference for treated and admitted to hospital noted among moderate-to-profound 
and unspecified IDs compared with mild. Compared with home without nursing or adult day 
services, those living in a group home and home with health service setting had lower ACSC 
treated and hospital admission rates (21.2% and 15.3% less respectively), whereas those 
living in a nursing home had 38.1% higher ACSC treated and hospital admission rates.
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Considering all variables in the models, women had 13.2% higher ACSC ED treated and 
discharged rates than men, and adults who were Caucasian experienced 10.5% lower rates 
than African American and other races. Those who were enrolled in the SNAP had 73.4% 
higher ACSC ED treated and discharged rates than those not receiving food stamps. Sex, 
race and nutrition assistance were not significant predictors of treated and subsequent 
hospitalisation rates. The presence of comorbidities greatly influenced both outcome 
measures. Having a primary care visit in the preceding year was associated with being more 
likely to have ACSC ED (treated and discharged or treated and admitted to the hospital) than 
not having a primary care visit −19.1% and 13.6%, respectively. Urban residence was 
associated with a 20% lower ACSC ED treated and admitted to hospital rate compared with 
those living in rural areas.
Discussion
This study assessed ACSC ED visits resulting in an inpatient hospitalisation or ED discharge 
and associated expenditures among people with ID controlling for ID subgroup, residential 
setting and other factors specific to SC Medicaid members. Adults with ID who lived at 
home or in unsupervised community settings without agency provided home support had 
higher rates of ACSC ED visits that resulted in discharge back to the community compared 
with adults with ID who live in group homes or other supervised environments or who live 
at home with health support services. Alternatively, ED utilisation that resulted in hospital 
admissions was highest in those living in nursing homes or other highly managed 
environments. Also, our findings revealed that adults with ID classified as mild and 
unspecified had higher rates of ACSC ED visits compared with adults with ID who have 
known genetic conditions or moderate or severe ID classifications. We found that Medicaid 
members with ID between 2001 and 2011 experienced over 21 000 potentially avoidable 
visits to the ED with costs exceeding $35 million. The findings show that ACSC ED visits, 
rates of discharge, inpatient hospitalisation and costs vary by ID subgroup and residential 
setting. It is noteworthy that the rank order of the ACSC diagnoses was similar across ID 
subgroup and residential setting, and these conditions represent opportunities to improve 
access to – or quality of – ambulatory care.
According to the National Hospital Ambulatory Medical Survey (CDC National Center for 
Health Statistics 2011), there were 44.5 ED visits per 100 people in 2011 and percentage of 
visits resulting in a hospital admission was 11.9%. In comparison, the average, unadjusted 
ED visit rate in 2011 for SC Medicaid members with ID was 110.5 visits per 100 people. 
The percentage of ED visits among SC Medicaid members with ID resulting in a hospital 
admission was 12.2%. Although members with Down syndrome and other genetic causes of 
ID and those with moderate-to-profound ID ED visit rates were high (66.6 and 77.5 per 100 
members, respectively) in comparison with the national average, members with mild and 
unspecified IDs experienced an ED visit rate three times as great as the national average 
(145.2 and 152.6 per 100 members, respectively).
We are aware of only two recent studies examining all-cause ED visits, for a wide range of 
reasons, in adults with ID due to any cause (Venkat et al. 2011; McDermott et al. 2015). 
Neither of these studies focused on ED visits associated with ACSC. Each study focused on 
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a cohort of individuals with ID, one included a group with Fragile X syndrome and a 
comparison group with other types of ID. While neither study considered residential setting, 
they did demonstrate that adults with ID had a higher rate of ED utilisation than adults in the 
general population, and those with significant comorbidities had higher rates of utilisation 
than those who did not. In a previous study, women with ID were found to have better rates 
of adherence with breast and cervical cancer screening if they lived in more managed 
settings (Xu et al. 2017).
We surmise that the reason people with mild and unspecified IDs and those who live in 
home settings without support had higher rates of ACSC visits to the ED is likely related to 
the fact that these individuals have less supervision by staff and the recognition of 
developing symptoms might be delayed, until the condition becomes more urgent. In fact, 
adults with mild ID might not qualify for either residential or other support services and 
have to rely on themselves, family or friends to identify signs and symptoms that would 
require a primary care appointment. In addition, it is possible that adults with mild and 
unspecified IDs might not have an established relationship with a primary care provider, in 
part because they have challenges with scheduling, communication, transportation and other 
aspects of coordinating their own healthcare.
Among those living in nursing homes and other settings where resident health is monitored 
and care provided, higher rates of ACSC hospital admission following an ED visit might be 
attributed to a greater prevalence and severity of comorbidity. Subsequent studies should 
explore this potential reason for the variation in rates of ACSC ED visits and subsequent 
hospitalisations across residential setting for adults with ID.
We found that having at least one primary care visit was associated with slightly but 
significantly increased rates of ED visits. This is counter-intuitive, as it is widely believed 
that improved access to primary care services can reduce rates of unnecessary ED use(Mann 
2014), including visits due to an ACSC (NH Department of Health & Human Services 
2005). We believe that the most likely explanation for the higher rate of ED visits due to 
ACSC among those who had a primary care visit is that there are underlying factors such as 
presence and severity of chronic diseases, and potentially individual or family attitudes 
related to seeking healthcare in general, that are associated with the propensity to seek both 
outpatient care and ED care. Additional research is needed to investigate this possibility.
Previous studies have used the Andersen Behavioural Model of Health Service Utilisation 
(Balogh et al. 2010; Balogh et al. 2011) to investigate risk factors for ACSC hospitalisation 
for individuals with ID, including age, race, sex, poverty status and the health status of 
individuals. This study contributes to the literature by including residential setting as a 
control variable in the model. Our finding that individuals with ID who live at home without 
health support services were more likely to have an ACSC ED visit and be discharged to the 
community compared with those living in a nursing home, ICF, other institutions or home 
with health support services is intriguing and may present an opportunity for intervention. 
Indeed, cost savings might be realised if this vulnerable population residing at home could 
be referred to disability accessible patient-centred medical homes that provide continuous 
and coordinated care (Machlin & Carper 2007; Agency for Healthcare Research and Quality 
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2012). The group of adults with ID who live at home, without home-based health supports, 
might be more likely to respond to preventive interventions, compared with the more 
medically challenged groups who reside in nursing home, ICF or other institutions.
This study has several limitations. First, we relied on diagnosis codes so the data likely 
included some errors and some lack of precision. For example, a provider may not have 
access to intelligence testing results for a person with borderline intellectual function and 
erroneously diagnose him or her with ID. Alternatively a nonspecific code for ID may be 
used when in fact an individual has an identifiable ID syndrome but has not been worked-up. 
Second, we did not use variables that described the specific services and support that each 
individual received in their community residential living environment. Therefore, we cannot 
make any determinations about why rates of ED visits for ACSC varied across residential 
setting. Third, it is possible that some individuals diagnosed with an ACSC in the ED setting 
actually had an underlying condition that would not have been amenable to outpatient care. 
For example, an individual could present with epilepsy but ultimately be diagnosed with a 
brain tumour causing intractable seizures. Even the most carefully developed system for 
providing high-quality primary care might not be capable of preventing all ACSC visits. 
Fourth, we did not consider how common ACSCs were in the IDD population in comparison 
with the general population. Fifth, the focus on ACSC ED visits presents an incomplete 
picture of the quality of care related to ACSC. Combining non-ED admission inpatient data 
with ED data presents a more complete picture (Agency for Healthcare Research and 
Quality 2007). This was beyond the scope of this analysis but would be an important 
contribution of future work. Sixth, our analyses present findings for South Carolina and 
might not be generalisable to other states and territories. Expanding this work to other states 
is a direction for future work.
Because ED visits are expensive compared with ambulatory care treatment, pinpointing why 
people with ID have difficulty accessing and/or receiving quality primary care is important if 
economic efficiencies are to be realised. In the meantime, care providers that support people 
with ID who live at home without support services might consider recommending them to 
disability accessible patient-centred medical homes that provide continuous and coordinated 
care.
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Table 1
ICD-9-CM codes, diagnosis descriptions and subgroupings used to identify adults with an ID
Diagnosis description ICD-9-CM diagnosis codes Subgroup
Down syndrome 758 Down syndrome and other genetic causes
Chromosomal anomalies and autosomal 
deletion syndromes
758.1, 758.2, 758.31, 758.32, 758.33 and 758.39 Down syndrome and other genetic causes
Fragile X syndrome 759.83 Down syndrome and other genetic causes
Tuberous sclerosis 759.5 Down syndrome and other genetic causes
Prader–Willi syndrome 759.81 Down syndrome and other genetic causes
Moderate-to-profound ID 318.0, 318.1 and 318.2 Moderate to profound
Mild ID 317 Mild
Unspecified ID 319 Unspecified
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Table 4
ACSC visit diagnoses by frequency for Medicaid members with ID aged 22–64 years, 2001–2011 (total visits 
= 21,214).
ACSC type ICD-9-CM codes and descriptions N %
Epilepsy Grand Mal and other epileptic conditions [345] and convulsions [780.3] 6288 29.64
Respiratory Asthma [493], bacterial pneumonia [481, 482.2, 482.3, 482.41, 482.42, 482.9, 483, 485, 486], chronic 
obstructive pulmonary disease [466.0, 491, 492, 494, 496], tuberculosis (nonpulmonary) [012–018] and 
pulmonary tuberculosis [011]
3054 14.4
ENT Severe ear, nose, and throat infections [382, 462, 463, 465, 472.1] 2761 13.01
UTI Kidney/urinary infection [590.0, 599.0, 599.9, 595.0, 595.9] 2528 11.92
Diabetes Diabetes [250.0–250.3, 250.8–250.9] 2250 10.61
Dehydration Volume depletion [276.5] 1503 7.08
Dental Dental conditions [521–523, 525, 528] 1112 5.24
Circulatory Angina [411.1, 411.8, 413], congestive heart failure [402.01, 402.11, 402.91, 428, 518.4] and hypertension 
[401.0, 401.9, 402.00, 402.10, 402.90]
919 4.33
Skin Cellulitis [681, 682, 683, 686] and skin grafts with cellulitis {DRGs: 263 and 264} 494 2.33
Immunisations Vaccine preventable conditions [032, 033, 037, 041.5, 045, 052.1, 052.9, 055–056, 070.0–070.3, 072, 320.3, 
390, 391, 771.0]
186 0.88
The remaining 119 ACSC visits were due to pelvic inflammatory disease [614], failure to thrive [783.41], iron deficiency 
anaemia [280.1, 280.8, 280.9] and nutritional deficiencies [260–262, 268.0, 268.1]
ACSC, ambulatory care sensitive condition.
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